2,3-Dimethyl-2H-indazol-6-amine dihydrochloride

Catalog No. :
ACWSNU678
CAS No. :
2446590-67-4
Molecular Formula :
C9H13Cl2N3
Molecular Weight :
234.13

IUPAC Name:2,3-dimethyl-2H-indazol-6-amine dihydrochloride

2,3-Dimethyl-2H-indazol-6-amine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$63.00Login to see priceIn stockInquiry
1g97%$125.00Login to see priceIn stockInquiry
5g97%$375.00Login to see priceIn stockInquiry
10g97%$686.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,3-Dimethyl-2H-indazol-6-amine dihydrochloride
IUPAC Name2,3-dimethyl-2H-indazol-6-amine dihydrochloride
MDL No.MFCD29472299
Molecular FormulaC9H13Cl2N3
Molecular Weight234.13
SMILESNC1=CC2=NN(C)C(C)=C2C=C1.[H]Cl.[H]Cl
InChI KeyFMCFATCZUACZQS-UHFFFAOYSA-N
Synonym2,3-Dimethyl-6-amino-2H-indazole (dihydrochloride);2H-Indazol-6-amine, 2,3-dimethyl-, hydrochloride (1:2)
CAS No.2446590-67-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACWSNU678 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOPZA481 route compound structure diagram
    ACOPZA481444731-73-1 In Stock
  2. Then
  3. ACWSNU678 route product structure diagram
    ACWSNU6782446590-67-4 In Stock
Inquiry

2. ACWSNU678 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACOPZA481 route compound structure diagram
    ACOPZA481444731-73-1 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWSNU678 route product structure diagram
    ACWSNU6782446590-67-4 In Stock
Inquiry

Comments (0)